JFL Life Sciences Limited (NSE:JFLLIFE)
India · Delayed Price · Currency is INR 9.45
0.00 (0.00%)
At close: Jun 15, 2026
JFL Life Sciences Market Cap
JFL Life Sciences has a market cap or net worth of 311.81 million as of June 18, 2026. Its market cap has decreased by -58.37% in one year.
Market Cap
311.81M
Enterprise Value
514.47M
Revenue
1.31B
Ranking
n/a
PE Ratio
4.87
Stock Price
9.45
Market Cap Chart
Since September 8, 2022, JFL Life Sciences's market cap has decreased from 731.40M to 311.81M, a decrease of -57.37%. That is a compound annual growth rate of -20.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 311.81M | -24.40% |
| Dec 31, 2025 | 412.44M | -59.35% |
| Dec 30, 2024 | 1.01B | 122.29% |
| Dec 29, 2023 | 456.44M | 22.06% |
| Dec 30, 2022 | 373.95M | -48.87% |
| Sep 8, 2022 | 731.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandu Pharmaceuticals | 414.46M |
| ANG Lifesciences India | 409.38M |
| Murae Organisor | 353.20M |
| Welcure Drugs and Pharmaceuticals | 346.06M |
| Panjon | 315.48M |
| Deccan Health Care | 296.33M |
| Gujarat Terce Laboratories | 264.59M |
| Parmax Pharma | 249.51M |